Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Penel

Showing results (121-130 of 350) with videos related to

Pageof 35
Sort By:
JMIR Mhealth and Uhealth|November 9, 2022
Shortening the Time Interval for the Referral of Patients With Soft Tissue Sarcoma to Expert Centers Using Mobile Health: Retrospective StudySimon Nannini, Nicolas Penel, Emmanuelle Bompas, et al.
The Lancet. Oncology|October 5, 2023
Pembrolizumab monotherapy for advanced chordoma - Authors' replyJean-Yves Blay, Nicolas Penel, Florence Duffaud, et al.
Bulletin Du Cancer|April 10, 2017
First-line management of metastatic castrate-resistant prostate cancer patients: Audit of real-life practicesAnthony Turpin, David Pasquier, Christophe Massard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008
Report of eight recent cases of locally advanced primary pulmonary artery sarcomas: failure of Doxorubicin-based chemotherapyNicolas Penel, Sophie Taieb, Luc Ceugnart, et al.
Critical Reviews in Oncology/Hematology|April 17, 2012
Management of "unfavourable" carcinoma of unknown primary site: synthesis of recent literatureEric Yaovi Amela, Géraldine Lauridant-Philippin, Sophie Cousin, et al.
American Journal of Clinical Oncology|August 27, 2019
Exceptional Long-lasting Clinical Benefit of Trabectedin in a Patient With Metastatic Undifferentiated Pleomorphic Sarcoma: Postscriptum From the T-Dis TrialNicolas Penel, Emilie Decoupigny, Emmanuelle Tresch-Bruneel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 19, 2017
Efficacy and safety of <sup>153</sup>Sm-EDTMP as treatment of painful bone metastasis: a large single-center studyHélène Kolesnikov-Gauthier, Nathalie Lemoine, Emmanuelle Tresch-Bruneel, et al.
Bulletin Du Cancer|December 12, 2018
[Epithelioid hemangioendothelioma]Sophie Cousin, François Le Loarer, Amandine Crombé, et al.
Investigational New Drugs|September 17, 2009
Justification of the starting dose as the main determinant of accrual time in dose-seeking oncology phase 1 trialsNicolas Penel, Pierre Leblond, Amélie Lansiaux, et al.
Patient Education and Counseling|January 1, 2026
Cancer progression and shared decision-making: CrossedJulia Kolly, Sophie Lelorain, Nicolas Penel, et al.
Pageof 35

Showing results (121-130 of 350) with videos related to

Sort By:
Pageof 35
JMIR Mhealth and Uhealth|November 9, 2022
Shortening the Time Interval for the Referral of Patients With Soft Tissue Sarcoma to Expert Centers Using Mobile Health: Retrospective StudySimon Nannini, Nicolas Penel, Emmanuelle Bompas, et al.
The Lancet. Oncology|October 5, 2023
Pembrolizumab monotherapy for advanced chordoma - Authors' replyJean-Yves Blay, Nicolas Penel, Florence Duffaud, et al.
Bulletin Du Cancer|April 10, 2017
First-line management of metastatic castrate-resistant prostate cancer patients: Audit of real-life practicesAnthony Turpin, David Pasquier, Christophe Massard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008
Report of eight recent cases of locally advanced primary pulmonary artery sarcomas: failure of Doxorubicin-based chemotherapyNicolas Penel, Sophie Taieb, Luc Ceugnart, et al.
Critical Reviews in Oncology/Hematology|April 17, 2012
Management of "unfavourable" carcinoma of unknown primary site: synthesis of recent literatureEric Yaovi Amela, Géraldine Lauridant-Philippin, Sophie Cousin, et al.
American Journal of Clinical Oncology|August 27, 2019
Exceptional Long-lasting Clinical Benefit of Trabectedin in a Patient With Metastatic Undifferentiated Pleomorphic Sarcoma: Postscriptum From the T-Dis TrialNicolas Penel, Emilie Decoupigny, Emmanuelle Tresch-Bruneel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 19, 2017
Efficacy and safety of <sup>153</sup>Sm-EDTMP as treatment of painful bone metastasis: a large single-center studyHélène Kolesnikov-Gauthier, Nathalie Lemoine, Emmanuelle Tresch-Bruneel, et al.
Bulletin Du Cancer|December 12, 2018
[Epithelioid hemangioendothelioma]Sophie Cousin, François Le Loarer, Amandine Crombé, et al.
Investigational New Drugs|September 17, 2009
Justification of the starting dose as the main determinant of accrual time in dose-seeking oncology phase 1 trialsNicolas Penel, Pierre Leblond, Amélie Lansiaux, et al.
Patient Education and Counseling|January 1, 2026
Cancer progression and shared decision-making: CrossedJulia Kolly, Sophie Lelorain, Nicolas Penel, et al.
Pageof 35